[SRNE] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
15-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -117.11%
YoY- -231.77%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 13,034 5,778 6,477 6,143 6,929 4,105 3,913 122.54%
PBT -69,110 -74,002 -70,654 -145,810 -55,746 -50,380 -74,081 -4.51%
Tax 309 -221 -383 -178 -3,122 -826 -1,377 -
NP -62,820 -64,415 -56,762 -108,071 -49,776 -47,328 -73,864 -10.20%
Tax Rate - - - - - - - -
Total Cost 75,854 70,193 63,239 114,214 56,705 51,433 77,777 -1.65%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin -481.97 -1,114.83 -876.36 -1,759.25 -718.37 -1,152.94 -1,887.66 -59.65%
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
EPS -0.34 -0.49 -0.46 -0.88 -0.41 -0.40 -0.73 -39.83%
EPS Diluted -0.34 -0.46 -0.43 -0.88 -0.41 -0.40 -0.73 -39.83%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.